Pfizer captive gets ‘Excellent’ rating affirmed

AM Best has affirmed the financial strength rating of ‘A’ (Excellent) and the long-term issuer credit rating of “a+” (Excellent) of Blue Whale Re Ltd.

Blue Whale Re is a pure captive owned by pharmaceutical giant Pfizer.

Subscribe to Ci Premium to continue reading

Captive Intelligence provides high-value information, industry analysis, exclusive interviews and business intelligence tools to professionals in the captive insurance market.

Start a FREE TRIAL now.

Or, view Membership Options and Group Discounts.

Already a subscriber? Log in here